<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK548685" /><meta name="ncbi_domain" content="livertox" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK548685/" /><meta name="ncbi_pagename" content="Beta-2 Adrenergic Agonists - LiverTox - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Beta-2 Adrenergic Agonists - LiverTox - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]" /><meta name="citation_title" content="Beta-2 Adrenergic Agonists" /><meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="citation_date" content="2017/09/11" /><meta name="citation_pmid" content="31643996" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK548685/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Beta-2 Adrenergic Agonists" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="DC.Date" content="2017/09/11" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK548685/" /><meta name="description" content="The beta-2 adrenergic agonists are a large group of drugs that mimic the actions of naturally occurring catecholamines such as norepinephrine, epinephrine and dopamine. Direct agonists directly interact with the adrenergic receptors, whereas indirect agonists typically stimulate the release of endogenous catecholamines. The beta-2 adrenergic agonists act mainly on the smooth muscle of the vasculature, bronchial tree, intestines and uterus. These agents also act on the liver stimulating glycogenolysis and release of glucose from the liver and muscle (particularly if used in high doses). The beta-2 adrenergic agonists are used largely as bronchodilators in the management of asthma, both in control of acute symptomatic attacks as well as chronic, long term prevention and management. These agents are some of the most commonly prescribed drugs for asthma and are widely used and proven to be well tolerated and safe. The use of beta adrenergic agonists in asthma has not been associated with elevations in serum aminotransferase or alkaline phosphatase levels or in causing clinically apparent liver disease. When given in large doses or after intentional overdose, beta adrenergic agonists can cause liver injury. Most case reports of liver damage from these agents have been associated with their use in control of premature labor (for their effects on relaxation of uterine smooth muscle). The liver injury typically arises within a few days of starting high dose intravenous beta adrenergic agonists, is usually asymptomatic, not associated with jaundice, and rapidly reversed once the medication is stopped." /><meta name="og:title" content="Beta-2 Adrenergic Agonists" /><meta name="og:type" content="book" /><meta name="og:description" content="The beta-2 adrenergic agonists are a large group of drugs that mimic the actions of naturally occurring catecholamines such as norepinephrine, epinephrine and dopamine. Direct agonists directly interact with the adrenergic receptors, whereas indirect agonists typically stimulate the release of endogenous catecholamines. The beta-2 adrenergic agonists act mainly on the smooth muscle of the vasculature, bronchial tree, intestines and uterus. These agents also act on the liver stimulating glycogenolysis and release of glucose from the liver and muscle (particularly if used in high doses). The beta-2 adrenergic agonists are used largely as bronchodilators in the management of asthma, both in control of acute symptomatic attacks as well as chronic, long term prevention and management. These agents are some of the most commonly prescribed drugs for asthma and are widely used and proven to be well tolerated and safe. The use of beta adrenergic agonists in asthma has not been associated with elevations in serum aminotransferase or alkaline phosphatase levels or in causing clinically apparent liver disease. When given in large doses or after intentional overdose, beta adrenergic agonists can cause liver injury. Most case reports of liver damage from these agents have been associated with their use in control of premature labor (for their effects on relaxation of uterine smooth muscle). The liver injury typically arises within a few days of starting high dose intravenous beta adrenergic agonists, is usually asymptomatic, not associated with jaundice, and rapidly reversed once the medication is stopped." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK548685/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/livertox/Beta2AdrenergicAgoni/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK548685/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A3D1C046554B100000000087C026E.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All Drug Records" href="/books/n/livertox/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" alt="Cover of LiverTox" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK548685_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK548685_dtls__"><div>Bethesda (MD): <a href="https://www.niddk.nih.gov/" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">National Institute of Diabetes and Digestive and Kidney Diseases</a>; 2012-.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/livertox/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search this book" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search this book" submit="false" style="padding: 0.1em 0.4em;" /></div></form></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Interferon/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Betaine/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK548685_"><span class="title" itemprop="name">Beta-2 Adrenergic Agonists</span></h1><p class="small">Last Update: <span itemprop="dateModified">September 11, 2017</span>.</p></div><div class="body-content whole_rhythm" itemprop="text"><div id="Beta2AdrenergicAgoni.OVERVIEW"><h2 id="_Beta2AdrenergicAgoni_OVERVIEW_">OVERVIEW</h2><div id="Beta2AdrenergicAgoni.Introduction"><h3>Introduction</h3><p>The beta-2 adrenergic agonists are a large group of drugs that mimic the actions of naturally occurring catecholamines such as norepinephrine, epinephrine and dopamine. Direct agonists directly interact with the adrenergic receptors, whereas indirect agonists typically stimulate the release of endogenous catecholamines. The beta-2 adrenergic agonists act mainly on the smooth muscle of the vasculature, bronchial tree, intestines and uterus. These agents also act on the liver stimulating glycogenolysis and release of glucose from the liver and muscle (particularly if used in high doses). The beta-2 adrenergic agonists are used largely as bronchodilators in the management of asthma, both in control of acute symptomatic attacks as well as chronic, long term prevention and management. These agents are some of the most commonly prescribed drugs for asthma and are widely used and proven to be well tolerated and safe. The use of beta adrenergic agonists in asthma has not been associated with elevations in serum aminotransferase or alkaline phosphatase levels or in causing clinically apparent liver disease. When given in large doses or after intentional overdose, beta adrenergic agonists can cause liver injury. Most case reports of liver damage from these agents have been associated with their use in control of premature labor (for their effects on relaxation of uterine smooth muscle). The liver injury typically arises within a few days of starting high dose intravenous beta adrenergic agonists, is usually asymptomatic, not associated with jaundice, and rapidly reversed once the medication is stopped.</p><p>Commonly used beta adrenergic drugs include albuterol, bitolterol, metaproterenol, pirbuterol, salmeterol and terbutaline. These agents share structural similarity and are discussed together.</p></div><div id="Beta2AdrenergicAgoni.Beta_Adrenergic_Ago"><h3>Beta Adrenergic Agonists Used for Asthma: Bitolterol, Formoterol, Metaproterenol, Pirbuterol, Salbutamol (Albuterol), Salmeterol, Terbutaline</h3><p>The beta adrenergic agonists act on bronchial smooth muscle inducing bronchodilation and relieving bronchospasm in asthma and chronic obstructive pulmonary disease with asthmatic features. Their use in asthma has not been associated with liver injury.</p><div id="Beta2AdrenergicAgoni.Background"><h4>Background</h4><p>The beta adrenergic agonists are potent bronchodilators that are widely used in the management of bronchial asthma. These agents act by engaging the beta-2 adrenergic receptors on smooth muscle of bronchial tissue, relieving bronchospasm and reducing airway resistance. They also act on smooth muscle of the vascular system, intestines and uterus. Common forms of beta adrenergic agonists include albuterol, bitolterol, fenoterol, formoterol, levalbuterol, metaproterenol, salmeterol, pirbuterol and terbutaline, which all have similar mechanisms of action, chemical structure, side effects and efficacy, but somewhat different pharmacokinetics allowing for differences in dosing regimens and duration of action. Most of these agents are administered by inhalation (alone or in combination with other bronchodilators or corticosteroids), with only albuterol and terbutaline being available in oral forms in the United States. Albuterol (also known as salbutamol) is available in generic forms and under the brand names of Proventil and Ventolin as 2 and 4 mg tablets as well as in aerosol and syrup solutions. The recommended regimen of albuterol is 2 to 4 mg orally 3 to 4 times a day. Sustained release formulations are available for twice daily dosing (4 and 8 mg). Salmeterol is available as an inhalation powder in generic forms and under the brand name of Serevent Diskus. The typical dosage is one inhalation (50 mcg) twice daily and it is recommended to be given with corticosteroids only. Systemic absorption is minimal. Terbutaline is available in generic forms and under the brand name of Brethine in tablets of 2.5 and 5 mg, the usual adult dosage being 5 mg three times daily. These oral forms of beta adrenergic agonists are approved as means of prevention and reversal of bronchospasm and are used largely in the therapy of asthma. Terbutaline is also available in parenteral formulations for use in acute bronchospasm and has also been used as therapy of premature labor. Common side effects of the beta adrenergic agonists include dizziness, headache, nervousness, tachycardia, palpitations, nausea and diaphoresis, largely due to their beta adrenergic effects on other organs. Rare, potentially severe adverse events include cardiovascular events, paradoxical worsening of asthma and acute hypersensitivity reactions.</p></div><div id="Beta2AdrenergicAgoni.Hepatotoxicity"><h4>Hepatotoxicity</h4><p>Prospective studies have shown that <a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> elevations occur in less than 1% of patients receiving long term oral therapy with typical beta adrenergic bronchodilators, but instances of clinically apparent liver injury have not been reported in any detail. However, several cases of acute elevations in serum aminotransferase levels have been described in pregnant women receiving high doses of beta adrenergic agents intravenously for prevention or control of premature labor (Case 1). Serum alkaline phosphatase, <a class="def" href="/books/n/livertox/glossary/def-item/glossary.gamma-glutamyl-transpeptidase-ggt-/">GGT</a> and bilirubin levels are generally normal or within the normal range for later stages of pregnancy. The serum aminotransferase elevations are usually asymptomatic, but may be associated with nausea and right upper quadrant pain. <a class="def" href="/books/n/livertox/glossary/def-item/glossary.bilirubin/">Bilirubin</a> elevations are minimal and cases with jaundice have not been reported. The abnormalities resolve promptly (within 1 to 3 weeks) upon stopping therapy and have not been associated with fatalities or chronic liver injury.</p><p>Likelihood score, oral beta-adrenergic agonists: E (unlikely cause of clinically apparent liver injury).</p><p>Likelihood score, intravenous terbutaline: C[H] (high doses of intravenous terbutaline are a probable cause of acute serum aminotransferase elevations that can be symptomatic and clinically apparent).</p></div><div id="Beta2AdrenergicAgoni.Mechanism_of_Hepato"><h4>Mechanism of Hepatotoxicity</h4><p>The mechanism of hepatic injury due to beta adrenergic agents is probably a direct hepatotoxicity associated with high dose, particularly intravenous, therapy.</p></div><div id="Beta2AdrenergicAgoni.Outcome_and_Managem"><h4>Outcome and Management</h4><p>Typically, liver enzyme abnormalities resolve rapidly after stopping beta adrenergic agents. No cases of fulminant hepatitis or chronic liver injury have been convincingly linked to use of these agents. The hepatotoxicity associated with high dose therapy is rapidly reversed and cases of recurrence upon reexposure to typical oral doses have not been reported.</p><p>Drug Class: <a href="/books/n/livertox/Anti-AsthmaDrugs/">Antiasthmatic Agents</a>, <a href="/books/NBK548685/">Beta-2 Adrenergic Agonists</a></p></div></div></div><div id="Beta2AdrenergicAgoni.CASE_REPORT_Terbuta"><h2 id="_Beta2AdrenergicAgoni_CASE_REPORT_Terbuta_">CASE REPORT</h2><div id="Beta2AdrenergicAgoni.Case_1._Serum_amino"><h3>Case 1. Serum aminotransferase elevations during intravenous terbutaline therapy of premature labor.</h3><p>[Modified from: Quinn PG, Sherman BW, Tavill AS, Gibas AL. Terbutaline hepatitis in pregnancy: report of two cases and literature review. Am J Gastroenterol 1994; 89: 781-4. <a href="https://www.ncbi.nlm.nih.gov/pubmed/8172156" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>]</p><p>A 34 year old woman developed premature labor during her 26th week of pregnancy and was treated with intravenous terbutaline. Approximately 5 weeks later, she was admitted with generalized pruritus and found to have marked elevations in serum aminotransferase levels (<a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> 223, <a class="def" href="/books/n/livertox/glossary/def-item/glossary.aspartate-aminotransferase-ast-/">AST</a> 129), but normal alkaline phosphatase levels for pregnancy and no jaundice (bilirubin 0.4 mg/dL). An ultrasound showed a normal liver and biliary tree. Tests for hepatitis A, B and C were negative as were autoantibodies. The pruritus and liver test abnormalities were initially attributed to cholestasis of pregnancy, but rising ALT levels (Table) led to a tentative diagnosis of terbutaline induced hepatotoxicity. Terbutaline was stopped and serum aminotransferase levels promptly declined. However, uterine contractions increased and the patient delivered 3 healthy babies 3 days later. In follow up 3 weeks after delivery, serum aminotransferase levels were normal.</p><div id="Beta2AdrenergicAgoni.Key_Points"><h4>Key Points</h4><div id="Beta2AdrenergicAgoni.T1" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548685/table/Beta2AdrenergicAgoni.T1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Beta2AdrenergicAgoni.T1_lrgtbl__"><table><thead><tr><th id="hd_h_Beta2AdrenergicAgoni.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Medication:</th><td rowspan="1" colspan="1" style="vertical-align:top;">Terbutaline (intravenous, ~3 mg/day)</td></tr></thead><tbody><tr><th headers="hd_h_Beta2AdrenergicAgoni.T1_1_1_1_1" id="hd_b_Beta2AdrenergicAgoni.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Pattern:</th><td headers="hd_b_Beta2AdrenergicAgoni.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Hepatocellular (<a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> elevations only)</td></tr><tr><th headers="hd_h_Beta2AdrenergicAgoni.T1_1_1_1_1" id="hd_b_Beta2AdrenergicAgoni.T1_1_1_2_1" rowspan="1" colspan="1" style="vertical-align:top;">Severity:</th><td headers="hd_b_Beta2AdrenergicAgoni.T1_1_1_2_1" rowspan="1" colspan="1" style="vertical-align:top;">1+ (aminotransferase elevations without jaundice)</td></tr><tr><th headers="hd_h_Beta2AdrenergicAgoni.T1_1_1_1_1" id="hd_b_Beta2AdrenergicAgoni.T1_1_1_3_1" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.latency/">Latency</a>:</th><td headers="hd_b_Beta2AdrenergicAgoni.T1_1_1_3_1" rowspan="1" colspan="1" style="vertical-align:top;">5 weeks (elevated <a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a>)</td></tr><tr><th headers="hd_h_Beta2AdrenergicAgoni.T1_1_1_1_1" id="hd_b_Beta2AdrenergicAgoni.T1_1_1_4_1" rowspan="1" colspan="1" style="vertical-align:top;">Recovery:</th><td headers="hd_b_Beta2AdrenergicAgoni.T1_1_1_4_1" rowspan="1" colspan="1" style="vertical-align:top;">&#x0003c;3 weeks</td></tr><tr><th headers="hd_h_Beta2AdrenergicAgoni.T1_1_1_1_1" id="hd_b_Beta2AdrenergicAgoni.T1_1_1_5_1" rowspan="1" colspan="1" style="vertical-align:top;">Other medications:</th><td headers="hd_b_Beta2AdrenergicAgoni.T1_1_1_5_1" rowspan="1" colspan="1" style="vertical-align:top;">Ampicillin, cholestyramine, hydoxyzine, aspirin, docusate, ferrous sulfate, prednisone (10 mg/day)</td></tr></tbody></table></div></div></div><div id="Beta2AdrenergicAgoni.Laboratory_Values"><h4>Laboratory Values</h4><div id="Beta2AdrenergicAgoni.T2" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548685/table/Beta2AdrenergicAgoni.T2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Beta2AdrenergicAgoni.T2_lrgtbl__"><table><thead><tr><th id="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Time After Starting</th><th id="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Time After Stopping</th><th id="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a>*<br /> (U/L)</th><th id="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Alk P<br /> (U/L)</th><th id="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.bilirubin/">Bilirubin</a> (mg/dL)</th><th id="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Other</th></tr></thead><tbody><tr><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1 hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2 hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3 hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4 hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5 hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" colspan="6" rowspan="1" style="vertical-align:top;">Terbutaline pump started at 26 weeks of gestation.</td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">39 days</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">223</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">267</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.4</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">40 days</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">350</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">41 days</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">620</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">42 days</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">710</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">44 days</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">2011</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">308</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.4</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">45 days</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">1073</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">47 days</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">950</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.pruritus/">Pruritus</a></td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">50 days</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">1320</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">51 days</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">920</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Terbutaline stopped</td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">53 days</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">2 days</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">710</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">54 days</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">3 days</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">180</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Caesarean delivery</td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">10 weeks</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">3 weeks</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">20</td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_1 hd_h_Beta2AdrenergicAgoni.T2_1_1_1_2" colspan="2" rowspan="1" style="vertical-align:top;"><b>Normal Values</b></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;56</b></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;1.2</b></td><td headers="hd_h_Beta2AdrenergicAgoni.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div></div><p>* Values estimated from Figure 1, Patient 2.</p></div><div id="Beta2AdrenergicAgoni.Comment"><h4>Comment</h4><p>The differential diagnosis of liver disease during pregnancy is challenging and includes viral hepatitis, cholestasis of pregnancy, acute fatty liver of pregnancy and drug induced liver disease. This patient was initially thought to have cholestasis of pregnancy with itching and abnormal serum enzyme elevations. However, the height of the <a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> elevations with normal alkaline phosphatase levels and bilirubin were atypical of cholestasis of pregnancy and the role of terbutaline was considered. <a class="def" href="/books/n/livertox/glossary/def-item/glossary.acute-fatty-liver/">Acute fatty liver</a> of pregnancy was excluded by the normal ultrasound. Stopping terbutaline led to a prompt decrease in ALT levels, but also triggered premature labor and delivery. The absence of bilirubin and alkaline phosphatase elevations supported the role of terbutaline induced liver injury in this patient. Asymptomatic but prominent elevations in serum aminotransferase levels have been reported with use of high doses of beta adrenergic agents in pregnant women.</p></div></div></div><div id="Beta2AdrenergicAgoni.PRODUCT_INFORMATION"><h2 id="_Beta2AdrenergicAgoni_PRODUCT_INFORMATION_">PRODUCT INFORMATION</h2><div id="Beta2AdrenergicAgoni.BPI" class="box"><p><b>REPRESENTATIVE TRADE NAMES</b></p><p>Albuterol &#x02013; Salbutamol, Proventil&#x000ae; HFA</p><p>Salmeterol &#x02013; Serevent&#x000ae;</p><p>Terbutaline &#x02013; Brethine&#x000ae;</p><p><b>DRUG CLASS</b></p><p>Antiasthmatic Agents</p><p><a href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&#x00026;query=terbutaline" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COMPLETE LABELING</a></p><p>Product labeling at DailyMed, National Library of Medicine, NIH</p></div></div><div id="Beta2AdrenergicAgoni.CHEMICAL_FORMULAS_A"><h2 id="_Beta2AdrenergicAgoni_CHEMICAL_FORMULAS_A_">CHEMICAL FORMULAS AND STRUCTURES</h2><div id="Beta2AdrenergicAgoni.T3" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548685/table/Beta2AdrenergicAgoni.T3/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Beta2AdrenergicAgoni.T3_lrgtbl__"><table><thead><tr><th id="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">DRUG</th><th id="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">CAS REGISTRY NUMBER</th><th id="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">MOLECULAR FORMULA</th><th id="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">STRUCTURE</th></tr></thead><tbody><tr><td headers="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Albuterol Sulfate</td><td headers="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/135001554" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">51022-70-9</a></td><td headers="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C13-H21-N-O3.1/2H2-O4-S</td><td headers="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK548685/bin/AlbuterolSulfate_Structure.jpg" alt="Albuterol Sulfate Chemical Structure" /></div></td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Salmeterol Xinafoate</td><td headers="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/135015426" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">94749-08-3</a></td><td headers="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C25-H37-N-O4.C11-H8-O3</td><td headers="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK548685/bin/SalmeterolXinafoate_Structure.jpg" alt="Salmeterol Xinafoate Chemical Structure" /></div></td></tr><tr><td headers="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Terbutaline Sulfate</td><td headers="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/134993921" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">23031-32-5</a></td><td headers="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C12-H19-N-O3.1/2H2-O4-S</td><td headers="hd_h_Beta2AdrenergicAgoni.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK548685/bin/TerbutalineSulfate_Structure.jpg" alt="Terbutaline Sulfate Chemical Structure" /></div></td></tr></tbody></table></div></div></div><div id="Beta2AdrenergicAgoni.ANNOTATED_BIBLIOGRA"><h2 id="_Beta2AdrenergicAgoni_ANNOTATED_BIBLIOGRA_">ANNOTATED BIBLIOGRAPHY</h2><p>References updated: 11 September 2017</p><ul class="first-line-outdent"><li><div class="bk_ref" id="Beta2AdrenergicAgoni.R1">Zimmerman HJ. Adrenergic agents used as tocolytic (uterine relaxing) drugs. Miscellaneous drugs and diagnostic chemicals. In, Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott, 1999, pp. 715.<div><i>(Expert review of liver injury published in 1999, mentions that at least 3 cases of acute hepatocellular injury have been described after use of terbutaline to arrest premature labor).</i></div></div></li><li><div class="bk_ref" id="Beta2AdrenergicAgoni.R2">Westfall TC, Westfall DP. Adrenergic agonists and antagonists. In, Brunton LL, Chabner BA, Knollman BC, eds. Goodman &#x00026; Gilman&#x02019;s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill, 2011, pp. 277-333.<div><i>(Textbook of pharmacology and therapeutics).</i></div></div></li><li><div class="bk_ref" id="Beta2AdrenergicAgoni.R3">Suzuki M, Inagaki K, Kihira M, Matsuzawa K, Ishikawa K, Ishizuka T. Maternal liver impairment associated with prolonged high-dose administration of terbutaline for premature labor. Obstet Gynecol 1985; 66 (3 Suppl): 14S-15S.  [<a href="/pubmed/4022509" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4022509</span></a>]<div><i>(32 year old pregnant woman with premature labor was treated with iv terbutaline and developed nausea and enzyme elevations [bilirubin 0.7 mg/dL, ALT 1000 U/L, Alk P 172 U/L] 1 week later, which fell to normal 2 weeks after stopping and 1 week after delivery).</i></div></div></li><li><div class="bk_ref" id="Beta2AdrenergicAgoni.R4">Wilczy&#x00144;ski J, Hauk-Szklarek E, Borowski P, Wysocki K, Kuydowicz J, Sa&#x00142;aci&#x00144;ska B. [Increased activity of aminotransferases (ALAT, AspAT) in pregnant women threatened with immature and premature delivery treated with fenoterol] Ginekol Pol 1993; 64: 117-9. Polish.  [<a href="/pubmed/8359736" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8359736</span></a>]</div></li><li><div class="bk_ref" id="Beta2AdrenergicAgoni.R5">Quinn PG, Sherman BW, Tavill AS, Gibas AL. Terbutaline hepatitis in pregnancy: report of two cases and literature review. Am J Gastroenterol 1994; 89: 781-4.  [<a href="/pubmed/8172156" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8172156</span></a>]<div><i>(33 and 34 year old pregnant women developed marked ALT elevations [peaking at 910 and 2011 U/L] without jaundice after 4 weeks of terbutaline therapy [oral and iv], resolving within 3-4 days of stopping to near normal levels, whereupon delivery occurred: Case 1).</i></div></div></li><li><div class="bk_ref" id="Beta2AdrenergicAgoni.R6">Fontaine P, G&#x000e9;h&#x000e9;not M, Goffin P, Horsmans Y. Fenoterol-induced hepatitis in a pregnant woman: a case report. Am J Obstet Gynecol 1996; 174: 1647-8.  [<a href="/pubmed/9065147" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9065147</span></a>]<div><i>(27 year old woman developed acute elevations in ALT [peak 12 times ULN] with normal GGT and bilirubin levels during high dose fenoterol therapy for premature labor, resolving within 2 weeks of stopping fenoterol).</i></div></div></li><li><div class="bk_ref" id="Beta2AdrenergicAgoni.R7">Edelman JM, Turpin JA, Bronsky EA, Grossman J, Kemp JP, Ghannam AF, DeLucca PT, at al. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group. Ann Intern Med 2000;132: 97-104.  [<a href="/pubmed/10644288" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10644288</span></a>]<div><i>(191 patients with exercise induced bronchospasm received either montelukast or salmeterol aerosol for 8 weeks; in discussion of safety there was no mention of liver side effects or ALT levels).</i></div></div></li><li><div class="bk_ref" id="Beta2AdrenergicAgoni.R8">Ibanez I, Perez E, Vidal X, Laporte JR. Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs. J Hepatol 2002; 37: 592-600. <a href="https://www.ncbi.nlm.nih.gov/pubmed/(Prospective%20study%20of%20acute%20serious%20liver%20disease%20over%206%20years%20found%20107%20cases%20of%20dili,%20salbutamol%20[terbutaline]%20listed%20as%20cause%20of%206%20cases).%3C/em%3E%3C/h3%3E%3C/li%3E%3Cli%3E%3Ch3%3E%20Sabat%C3%A9%20M,%20Ib%C3%A1%C3%B1ez%20L,%20P%C3%A9rez%20E,%20et%20al.%20Risk%20of%20acute%20liver%20injury%20associated%20with%20the%20use%20of%20drugs:%20a%20multicentre%20population%20survey.%20Aliment%20Pharmacol%20Ther%202007;%2025:%201401-9.%20%3Ca%20href=" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>. [<a href="/pubmed/12399224" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12399224</span></a>]<div><i>(Prospective study of acute serious liver disease occurring over 6 years in Catalonia, Spain found 107 cases of drug induced liver injury, 3 of which were attributed to salbutamol [albuterol], but no clinical details given).</i></div></div></li><li><div class="bk_ref" id="Beta2AdrenergicAgoni.R9">Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, et al.; United States Drug Induced Liver Injury Network. Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study. Gastroenterology 2015; 148: 1340-52.e7.  [<a href="/pmc/articles/PMC4446235/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4446235</span></a>] [<a href="/pubmed/25754159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25754159</span></a>]<div><i>(Among 899 cases of drug induced liver injury enrolled in a US prospective study between 2004 and 2013, no cases were attributed to albuterol or terbutaline or other oral or inhalational beta adrenergic agonists).</i></div></div></li></ul></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK548685</span><span class="label">PMID: <a href="/pubmed/31643996" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31643996</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Interferon/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Betaine/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK548685&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK548685/?report=reader">PubReader</a></li><li><a href="/books/NBK548685/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK548685" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK548685" style="display:none" title="Cite this Page"><div class="bk_tt">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.  Beta-2 Adrenergic Agonists. [Updated 2017 Sep 11].<span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK548685/pdf/Bookshelf_NBK548685.pdf">PDF version of this page</a> (114K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Bulk Download</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://ftp.ncbi.nlm.nih.gov/pub/litarch/29/31/" ref="pagearea=source-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Bulk download LiverTox data from FTP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Overviews</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/intro/">Introduction</a></li><li><a href="/books/n/livertox/Causality/">Causality</a></li><li><a href="/books/n/livertox/ClinicalCourse/">Clinical Course</a></li><li><a href="/books/n/livertox/ClinicalOutcome/">Clinical Outcomes</a></li><li><a href="/books/n/livertox/ImmuneFeatures/">Immune Features</a></li><li><a href="/books/n/livertox/DrugCategory/">Likelihood Scale</a></li><li><a href="/books/n/livertox/Phenotypes_intro/">Phenotypes</a></li><li><a href="/books/n/livertox/Severity/">Severity Grading</a></li><li><a href="/books/n/livertox/CaseReport/">Writing a Case Report</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Support Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/">LiverTox Homepage</a></li><li><a href="/books/n/livertox/aboutus/">About LiverTox</a></li><li><a href="/books/n/livertox/editorsandreviewers/">Editors and Review Committee</a></li><li><a href="/books/n/livertox/alert/">Meetings and News</a></li><li><a href="/books/n/livertox/abbreviation/">Abbreviations Used</a></li><li><a href="/books/n/livertox/glossary/">Glossary</a></li><li><a href="/books/n/livertox/resource/">Information Resources</a></li><li><a href="/books/n/livertox/disclaimer/">User/Medical Advice Disclaimer</a></li><li><a href="/books/n/livertox/Contactus/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>OTHER REFERENCE LINKS</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;pubmedfilters=true&amp;term=(Terbutaline/AE)+AND+Human%5BMH%5D+AND+(drug+induced+liver+injury+OR+jaundice/CI+OR+bile+duct+diseases/CI+OR+liver/DE+OR+liver+diseases/CI)+AND+(%221900/1/1%22%5BEDat%5D%3A%222999/12/31%22%5BEDat%5D)" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Recent References on Terbutaline: from PubMed.gov</a></li><li><a href="https://clinicaltrials.gov/ct2/results?term=Terbutaline" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Trials on Terbutaline: from ClinicalTrials.gov</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4864934" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pcsubstance&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pcsubstance&amp;IdsFromResult=4864934" ref="log$=recordlinks">PubChem Substance</a><div class="brieflinkpop offscreen_noflow">Related PubChem Substances</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4864934" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12205813" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [The beta-2-agonists in asthma in infants and young children].</a><span class="source">[Arch Pediatr. 2002]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [The beta-2-agonists in asthma in infants and young children].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dubus JC, Mly L, Stremler-Lebel N, Chabrol B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Arch Pediatr. 2002 Aug; 9 Suppl 3:384s-389s. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/18292436" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">The effect of maternal catecholamines on the caliber of gravid uterine microvessels.</a><span class="source">[Anesth Analg. 2008]</span><div class="brieflinkpop offscreen_noflow">The effect of maternal catecholamines on the caliber of gravid uterine microvessels.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Segal S, Wang SY. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Anesth Analg. 2008 Mar; 106(3):888-92, table of contents. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12917905" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Long acting beta-agonists versus theophylline for maintenance treatment of asthma.</a><span class="source">[Cochrane Database Syst Rev. 2003]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Long acting beta-agonists versus theophylline for maintenance treatment of asthma.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shah L, Wilson AJ, Gibson PG, Coughlan J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cochrane Database Syst Rev. 2003; (3):CD001281. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/11293649" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?</a><span class="source">[Drugs. 2001]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Holimon TD, Chafin CC, Self TH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Drugs. 2001; 61(3):391-418. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/8105155" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Salmeterol: an inhaled beta 2-agonist with prolonged duration of action.</a><span class="source">[Lung. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Salmeterol: an inhaled beta 2-agonist with prolonged duration of action.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ltvall J, Svedmyr N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Lung. 1993; 171(5):249-64. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31643996" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31643996" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=60467952ddcb804c59b8fe15">Beta-2 Adrenergic Agonists - LiverTox</a><div class="ralinkpop offscreen_noflow">Beta-2 Adrenergic Agonists - LiverTox<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2021-03-08T14:21:54-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@9.2&amp;Host=portal103&amp;ncbi_phid=CE8A3D1C046554B100000000087C026E&amp;ncbi_session=CE8A3D1C04679511_2172SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK548685%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK548685&amp;ncbi_domain=livertox&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK548685/&amp;ncbi_pagename=Beta-2 Adrenergic Agonists - LiverTox - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A3D1C04679511_2172SID /projects/books/PBooks@9.2 portal103 v4.1.r621975 Fri, Dec 18 2020 02:56:50 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>